3 completed, 1 active not recruiting, 1 not yet recruiting. 2 Not applicable, 2 Phase 3, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 2 |
| Phase 3 | 2 | Active not recruiting 1, Not yet recruiting 1 |
| Phase 2 | 1 | Completed 1 |
Follow Ablative Solutions, Inc.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Renal Artery Denervation Assessment Without Antihypertensive Medication Regimen (RADAR) Dehydrated Alcohol Injection, USP, Sham procedure - Hypertension, Hypertension,Essential | Phase 3 | Not yet recruiting | Ablative Solutions, Inc. | 202 | 2026-10-01 | 2026-08-20 |
| TARGET BP I Clinical Trial Dehydrated alcohol, Peregrine System Kit (Sham Procedure) - Hypertension | Phase 3 | Active not recruiting | Ablative Solutions, Inc. | 300 | 2019-07-22 | 2023-10-03 |
| The TARGET BP OFF-MED Trial Alcohol, Sham control - Hypertension, Hypertension,Essential | Phase 2 | Completed | Ablative Solutions, Inc. | 350 | 2018-09-24 | 2025-05-14 |
| The Peregrine Post-Market Study for the Treatment of Hypertension Peregrine System Infusion Catheter - Hypertension | Not applicable | Completed | Ablative Solutions, Inc. | 45 | 2015-11-01 | 2023-09-28 |
| The Peregrine Study: A Safety and Performance Study of Renal Denervation The Peregrine System Infusion Catheter - Hypertension | Not applicable | Completed | Ablative Solutions, Inc. | 10 | 2014-07-01 | 2018-06-14 |
Hypertension (5) · Essential Hypertension (2)
Ethanol (3)
Belgium (2) · Czechia (2) · Germany (2) · Poland (2) · United States (2) · France (1) · United Kingdom (1)
Atul Pathak, Prof. (2) · David Kandzari, MD (2) · Michael Weber, MD (2) · Atul Pathak, MD (1) · Felix Mahfoud, MD (1) · Felix Mahfoud, Prof.Dr. med (1) · Felix Mahfoud, Prof.Dr.med. (1) · Gregg Stone, MD (1) · Horst Sievert, MD (1) · Wojciech Wojakowski, Prof.MD.PhD (1)